News

Corin soaring

28 August 2008 14:22:00

Orthopaedic devices manufacturer Corin put its best foot forward as it announced sharp increases in sales and underlying profits.

Sales rose 63%, or 55% on a constant currency basis, to £22.9m in the first half of 2008 from £14m a year earlier, reflecting the roll-out of its Cormet hip resurfacing system in the USA.

Underlying pre-tax profit, which excludes exceptional items, more than tripled to £3.7m from £1.2m. As reported pre-tax profit grew from £1.2m to £1.8m.

The management has concluded a strategic review of the group's operations and has decided to pursue a more balanced strategy, focusing on urther development of the group's leading technologies and products in metal-on-metal hips and mobile bearing knees, development of a comprehensive hip and knee implant product portfolio and increased investment in sales teams in key geographic areas.

The medium term target of the new strategy is to achieve long-lasting double-digit sales growth and margin enhancement.

As a result of the new strategic focus, the company will discontinue a number of older or non-core products. This will have only a small effect on sales but will entail a significant write-off of unsold stock.

Trading at the start of the second half of the year has been in line with expectations although, as previously announced, sales of Cormet in the USA are growing more slowly than originally envisaged and are likely to be lower in 2009 than in 2008.

The interim dividend has been retained at 0.48p.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.